Publicacións en colaboración con investigadores/as de Hospital Universitari Germans Trias i Pujol (23)

2024

  1. A multitrait genetic study of hemostatic factors and hemorrhagic transformation after stroke treatment

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 4, pp. 936-950

2021

  1. Article targeting pro-oxidant iron with deferoxamine as a treatment for ischemic stroke: Safety and optimal dose selection in a randomized clinical trial

    Antioxidants, Vol. 10, Núm. 8

  2. Early Neurological Change After Ischemic Stroke Is Associated With 90-Day Outcome

    Stroke, Vol. 52, Núm. 1, pp. 132-141

  3. Rp11-362k2.2:Rp11-767i20.1 genetic variation is associated with post-reperfusion therapy parenchymal hematoma. a gwas meta-analysis

    Journal of Clinical Medicine, Vol. 10, Núm. 14

2020

  1. Association of High Serum Levels of Growth Factors with Good Outcome in Ischemic Stroke: a Multicenter Study

    Translational Stroke Research, Vol. 11, Núm. 4, pp. 653-663

  2. Genome-Wide Association Study of VKORC1 and CYP2C9 on acenocoumarol dose, stroke recurrence and intracranial haemorrhage in Spain

    Scientific Reports, Vol. 10, Núm. 1

2014

  1. Prestroke physical activity is associated with good functional outcome and arterial recanalization after stroke due to a large vessel occlusion

    Cerebrovascular Diseases, Vol. 37, Núm. 4, pp. 304-311

2013

  1. Interleukin-10 facilitates the selection of patients for systemic thrombolysis

    BMC Neurology, Vol. 13

  2. Microbleed burden and hematoma expansion in acute intracerebral hemorrhage on behalf of the RENEVAS group (Stroke Research Network, RETICS, Instituto de Salud Carlos III)

    European Neurology, Vol. 70, Núm. 3-4, pp. 175-178

  3. Neuronal excitotoxicity after carotid angioplasty and stent placement procedures

    Radiology, Vol. 268, Núm. 2, pp. 515-520

2012

  1. A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA)

    Clinical Science, Vol. 122, Núm. 3, pp. 113-119

2011

  1. Early biomarkers of clinical-diffusion mismatch in acute ischemic stroke

    Stroke, Vol. 42, Núm. 10, pp. 2813-2818

  2. The human Tp53 Arg72Pro polymorphism explains different functional prognosis in stroke

    Journal of Experimental Medicine, Vol. 208, Núm. 3, pp. 429-437

2010

  1. Iron-related brain damage in patients with intracerebral hemorrhage

    Stroke, Vol. 41, Núm. 4, pp. 810-813

2009

  1. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation

    Atherosclerosis, Vol. 205, Núm. 2, pp. 561-567

2008

  1. High plasma glutamate concentrations are associated with infarct growth in acute ischemic stroke

    Neurology, Vol. 71, Núm. 23, pp. 1862-1868

  2. High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA

    Stroke, Vol. 39, Núm. 7, pp. 2006-2010

  3. Marcadores moleculares asociados a signos precoces de isquemia en tomografía computarizada cerebral

    Neurologia, Vol. 23, Núm. 4, pp. 220-225

2007

  1. Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: A multicenter confirmatory study

    Stroke, Vol. 38, Núm. 6, pp. 1855-1859

2006

  1. A polymorphism in the EAAT2 promoter is associated with higher glutamate concentrations and higher frequency of progressing stroke

    Journal of Experimental Medicine, Vol. 203, Núm. 3, pp. 711-717